ERBB2 and cancer: As discussed in this review, MIP-based biosensors have many diagnostic possibilities for detecting various cancer biomarkers, such as proteins (PSA, Myo, CA15-3, HER-2, CA-125) or small-weight molecules (5-HIAA, neopterin) due to their robustness, sensitivity, and inexpensive analysis.